David J. Yvars Group’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $35.8K | Buy |
27,550
+7,250
| +36% | +$10.5K | 0.02% | 106 |
|
|
2026
Q1 | $29.4K | Sell |
20,300
-10,930
| -35% | -$17.3K | 0.02% | 92 |
|
|
2025
Q4 | $43.1K | Buy |
31,230
+5,650
| +22% | +$11.8K | 0.02% | 92 |
|
|
2025
Q3 | $69.8K | Buy |
25,580
+1,505
| +6% | +$5.35K | 0.04% | 93 |
|
|
2025
Q2 | $84K | Sell |
24,075
-425
| -2% | -$1.68K | 0.05% | 82 |
|
|
2025
Q1 | $90.2K | Sell |
24,500
-21,825
| -47% | -$79.7K | 0.07% | 66 |
|
|
2024
Q4 | $74.6K | Buy |
46,325
+14,825
| +47% | +$15.4K | 0.05% | 78 |
|
|
2024
Q3 | $23.9K | Sell |
31,500
-35,000
| -53% | -$45.9K | 0.01% | 80 |
|
|
2024
Q2 | $120K | Sell |
66,500
-3,220
| -5% | -$9.29K | 0.07% | 74 |
|
|
2024
Q1 | $332K | Sell |
69,720
-5,210
| -7% | -$18.3K | 0.22% | 54 |
|
|
2023
Q4 | $217K | Buy |
74,930
+38,930
| +108% | +$61.4K | 0.17% | 65 |
|
|
2023
Q3 | $48.6K | Buy |
36,000
+3,500
| +11% | +$6.13K | 0.04% | 78 |
|
|
2023
Q2 | $69.9K | Buy |
32,500
+16,850
| +108% | +$40.9K | 0.06% | 81 |
|
|
2023
Q1 | $45.5K | Sell |
15,650
-21,770
| -58% | -$110K | 0.04% | 79 |
|
|
2022
Q4 | $257K | Buy |
37,420
+11,800
| +46% | +$55.7K | 0.32% | 49 |
|
|
2022
Q3 | $81K | Buy |
25,620
+10,000
| +64% | +$36.3K | 0.09% | 66 |
|
|
2022
Q2 | $50K | Buy |
15,620
+5,495
| +54% | +$16K | 0.07% | 62 |
|
|
2022
Q1 | $31K | Buy |
+10,125
| New | +$34.2K | 0.02% | 80 |
|
|
2021
Q3 | – | Sell |
-32,740
| Closed | -$524K | – | 91 |
|
|
2021
Q2 | $524K | Buy |
32,740
+13,010
| +66% | +$180K | 0.29% | 51 |
|
|
2021
Q1 | $244K | Sell |
19,730
-31,825
| -62% | -$488K | 0.16% | 70 |
|
|
2020
Q4 | $573K | Buy |
+51,555
| New | +$387K | 0.39% | 37 |
|
Other funds holding STIM
David J. Yvars Group's STIM Position: Q2 2026 in Review
David J. Yvars Group increased its Neuronetics (STIM) stake by 36% in Q2 2026, buying an estimated $10.5K and bringing the position to 27,550 shares worth $35.8K. The position accounts for 0.02% of the portfolio, ranked #106.
David J. Yvars Group first reported a position in STIM in Q4 2020 and has held it in 21 quarters since. The position peaked at $573K in Q4 2020. 4 funds tracked by Wall St. Rank hold STIM as of Q2 2026.
- David J. Yvars Group held 27,550 shares of Neuronetics worth $35.8K as of Q2 2026.
- David J. Yvars Group bought 7,250 Neuronetics shares in Q2 2026, an estimated $10.5K.
- Neuronetics made up 0.02% of David J. Yvars Group's portfolio in Q2 2026, its #106 holding.
- David J. Yvars Group first reported a position in Neuronetics in Q4 2020 and has held it in 21 quarters since.
- David J. Yvars Group's Neuronetics position peaked at $573K in Q4 2020.
- 4 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.
Based on David J. Yvars Group's 13F filing for Q2 2026, filed 7 Jul 2026.